INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Zalicus, Inc. & Its Board of Directors In Connection With th...
April 23 2014 - 3:30PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Zalicus, Inc. (“Zalicus” or “the Company”) (NasdaqCM:ZLCS) for
possible breaches of fiduciary duty and other violations of state
law in connection with the sale of the Company to Epirus
Biopharmaceuticals.
Click here to learn more about the action
http://zlk.9nl.com/zalicus-zlcs, or call: 877-363-5972.
There is no cost or obligation to you.
Under the terms of the transaction, Zalicus shareholders will
own a percentage of the post-merger company; this percentage is
subject to an adjustment at closing based on the level of Zalicus
net cash. Based on Zalicus’ net cash as of April 16, 2014, the day
the merger was announced, Zalicus shareholders would own just 14%
of the combined company. The investigation concerns whether the
Zalicus Board of directors breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Epirus
Biopharmaceuticals is underpaying for Zalicus shares.
If you own Zalicus common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/zalicus-zlcs.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s 26
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
EPIRUS Biopharmaceuticals (CE) (USOTC:EPRSQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
EPIRUS Biopharmaceuticals (CE) (USOTC:EPRSQ)
Historical Stock Chart
From Apr 2023 to Apr 2024